| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882871 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 6 Pages |
Abstract
DNMT3A is frequently mutated in T-ALL and is associated with distinct clinicopathologic entities and a poor prognosis. These findings could help in risk stratification and treatment decisions for patients with T-ALL.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Salah Aref, Nadia El Menshawy, Mohamed Sabry El-Ghonemy, Tarek Abou Zeid, Mohamed Ali El-Baiomy,